Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 19
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we hear how mycelia communicate?

    Mycelial networks are the root like structures of fruiting body mushrooms. Spontaneous electrical low-frequency...

    Why do spiders decorate their webs?

    Many spiders decorate their webs with conspicuous UV-reflecting designs, what makes them bright for some...

    Monitoring elusive wildlife species in Lake Manyara National Park, Tanzania

    Lake Manyara National Park, located in northern Tanzania, harbors several mammal species of conservation...

    Backer Badge Funded